- Jun, Gyungah R
- Chung, Jaeyoon
- Mez, Jesse
- Barber, Robert
- Beecham, Gary W
- Bennett, David A
- Buxbaum, Joseph D
- Byrd, Goldie S
- Carrasquillo, Minerva M
- Crane, Paul K
- Cruchaga, Carlos
- De Jager, Philip
- Ertekin-Taner, Nilufer
- Evans, Denis
- Fallin, M Danielle
- Foroud, Tatiana M
- Friedland, Robert P
- Goate, Alison M
- Graff-Radford, Neill R
- Hendrie, Hugh
- Hall, Kathleen S
- Hamilton-Nelson, Kara L
- Inzelberg, Rivka
- Kamboh, M Ilyas
- Kauwe, John SK
- Kukull, Walter A
- Kunkle, Brian W
- Kuwano, Ryozo
- Larson, Eric B
- Logue, Mark W
- Manly, Jennifer J
- Martin, Eden R
- Montine, Thomas J
- Mukherjee, Shubhabrata
- Naj, Adam
- Reiman, Eric M
- Reitz, Christiane
- Sherva, Richard
- St George-Hyslop, Peter H
- Thornton, Timothy
- Younkin, Steven G
- Vardarajan, Badri N
- Wang, Li-San
- Wendlund, Jens R
- Winslow, Ashley R
- Alzheimer's Disease Genetics Consortium
- Haines, Jonathan
- Mayeux, Richard
- Pericak-Vance, Margaret A
- Schellenberg, Gerard
- Lunetta, Kathryn L
- Farrer, Lindsay A
- et al.
Introduction
Genetic loci for Alzheimer's disease (AD) have been identified in whites of European ancestry, but the genetic architecture of AD among other populations is less understood.Methods
We conducted a transethnic genome-wide association study (GWAS) for late-onset AD in Stage 1 sample including whites of European Ancestry, African-Americans, Japanese, and Israeli-Arabs assembled by the Alzheimer's Disease Genetics Consortium. Suggestive results from Stage 1 from novel loci were followed up using summarized results in the International Genomics Alzheimer's Project GWAS dataset.Results
Genome-wide significant (GWS) associations in single-nucleotide polymorphism (SNP)-based tests (P < 5 × 10-8) were identified for SNPs in PFDN1/HBEGF, USP6NL/ECHDC3, and BZRAP1-AS1 and for the interaction of the (apolipoprotein E) APOE ε4 allele with NFIC SNP. We also obtained GWS evidence (P < 2.7 × 10-6) for gene-based association in the total sample with a novel locus, TPBG (P = 1.8 × 10-6).Discussion
Our findings highlight the value of transethnic studies for identifying novel AD susceptibility loci.